Doubly Unsaturated Trifluoromethyl Amines
FULL PAPER
10.2 Hz, 1 H), 5.1 (d, J = 17.3 Hz, 1 H), 5.7 (m, 1 H), 6.8 (m, 4 H) 17.8 Hz, 1 H), 2.4 (d, J = 17.8 Hz, 1 H), 2.9 (d, J = 15.9 Hz, 1 H),
ppm. 13C NMR: δ = 21.9, 34.9, 47.9, 55.1, 61.0 (q, 2JC,F = 27.0 Hz), 3.1 (d, J = 15.9 Hz, 1 H), 3.3 (qt, J = 9.1, 2.3 Hz, 1 H), 3.8 (dq, J
1
114.0, 114.2, 116.4, 118.6, 126.7 (q, JC,F = 288 Hz), 135.6, 140.3,
142.3, 153.3 ppm. 19F NMR: δ = –72.2 (d, J = 8.0 Hz, CF3) ppm.
C16H20F3NO (299.33): calcd. C 64.20, H 6.73, N 4.68; found C
63.98, H 6.91, N 4.52.
= 13.6, 1.6 Hz, 1 H), 3.9 (d, J = 13.6 Hz, 1 H), 5.3 (s, 1 H), 7.1–
2
7.3 (m, 5 H) ppm. 13C NMR: δ = 20.6, 24.1, 51.4, 55.9 (q, JC,F
=
25.0 Hz), 58.9, 115.8, 127.2, 127.8 (q, 1JC,F = 292 Hz), 128.4, 128.5,
132.1, 138.8 ppm. 19F NMR: δ = –68.5 (d, J = 9.0 Hz, CF3) ppm.
C14H16F3N (255.29): calcd. C 65.87, H 6.32, N 5.49; found C 65.80,
H 6.66, N 5.41.
(–)-N-Allyl-N-(2-methoxy-1-phenylethyl)[1-(trifluoromethyl)but-3-en-
yl]amine (16): From imine 3 (462 mg, 2 mmol), allyl bromide (1.3 g,
10.8 mmol), and CuI (571 mg, 3 mmol), 16 was obtained as a
brown oil (338 mg, 54%). [α]2D5 = –32.4 (c = 1.02 in MeOH). 1H
NMR: δ = 2.1 (m, 2 H) 3.2 (s, 3 H), 3.3 (m, 3 H), 3.6 (d, J =
6.4 Hz, 2 H), 4.1 (t, J = 6.4 Hz, 1 H), 4.80 (d, J = 16.7 Hz, 1 H),
4.83 (d, J = 10.3 Hz, 1 H), 5.0 (d, J = 10.0 Hz, 1 H), 5.1 (d, J =
17.0 Hz, 1 H), 5.4 (ddt, J = 17.0, 10.3, 6.9 Hz, 1 H), 5.7 (ddt, J =
16.8, 10.0, 6.2 Hz, 1 H), 7.2 (m, 5 H) ppm. 13C NMR: δ = 31.5,
50.2, 58.7, 59.1 (q, J = 27.0 Hz), 61.7, 73.8, 116.8, 117.0, 127.1 (q,
J = 287.0 Hz), 127.4, 128.3, 128.4, 134.4, 137.3, 139.7 ppm. 19F
NMR: δ = –71.7 (d, J = 8.3 Hz, CF3) ppm. C17H22F3NO (313.36):
calcd. C 65.16, H 7.08, N 4.47; found C 65.22, H 7.09, N 4.21.
1-Benzyl-2-trifluoromethyl-5-vinyl-1,2,3,6-tetrahydropyridine (21):
Starting from 12 (267 mg, 1 mmol) and the Grubbs catalyst (44 mg,
10 mol-%), compound 21 was obtained as a clear, brown liquid
1
(253 mg, 95%). H NMR: δ = 2.3 (d, J = 19.0 Hz, 1 H), 2.6 (d, J
= 19.0 Hz, 1 H), 3.3 (dq, J = 9.0, 2.2 Hz, 1 H), 3.8 (d, J = 13.6 Hz,
1 H), 4.0 (d, J = 13.6 Hz, 1 H), 4.83 (d, J = 17.6 Hz, 1 H), 4.84 (d,
J = 11.0 Hz, 1 H), 5.7 (s, 1 H), 6.2 (dd, J = 17.6, 11.0 Hz, 1 H),
7.4–7.5 (m, 5 H) ppm. 13C NMR: δ = 24.5 (q, 3JC,F = 2.0 Hz), 46.5
3
2
(q, JC,F = 0.6 Hz), 56.0 (q, JC,F = 25.8 Hz), 59.1, 110.8, 123.1,
127.3, 127.6 (q, 1JC,F = 292 Hz), 128.4, 128.5, 134.2 (q, J = 0.7 Hz),
136.9, 138.5 (q, J = 0.5 Hz) ppm. 19F NMR: δ = –68.8 (d, J =
9.0 Hz, CF3) ppm. C15H16F3N (267.29): calcd. C 67.40, H 6.03, N
5.23; found C 67.38, H 6.02, N 5.32.
General Procedure for the Ring-Closing Metathesis. Synthesis of
Compounds 17–24: Di-ω-dienes 7–16 and the Grubbs catalyst (5–
10 mol-%) were dissolved in CH2Cl2 under an argon atmosphere.
After 2–48 h (monitored by GC), the solvent was evaporated and
the crude mixture was purified over silica gel (petroleum ether/Ac-
OEt, 9:1) to afford 17–24.
1-(4-Methoxyphenyl)-2-trifluoromethyl-1,2,3,6-tetrahydropyridine
(22): Starting from 11 (57 mg, 0.45 mmol) and the Grubbs catalyst
(18 mg, 5 mol-%), compound 22 was obtained as a clear, brown
liquid (104 mg, 90%). 1H NMR: δ = 2.3 (m, 2 H), 2.6 (m, 2 H),
3.7 (s, 3 H), 4.3 (quint, J = 9.0 Hz, 1 H), 5.8 (s, 2 H), 6.8 (m, 4 H)
1-Benzyl-2-trifluoromethyl-1,2,3,6-tetrahydropyridine (17): Starting
from 7 (121 mg, 0.45 mmol) and the Grubbs catalyst (18 mg, 5 mol-
%), compound 17 was obtained as a clear, brown liquid (103 mg,
95%). 1H NMR: δ = 2.2 (m, 1 H), 2.5 (m, 1 H), 3.1 (d, J = 16 Hz,
1 H), 3.3 (d, J = 16 Hz, 1 H), 3.4 (m, 1 H), 3.7 (d, J = 14 Hz, 1
H), 3.9 (d, J = 14 Hz, 1 H), 5.7 (d, J = 2.0 Hz, 2 H), 7.2–7.4 (m, 5
2
ppm. 13C NMR: δ = 24.0, 44.2, 54.4 (q, JC,F = 30.0 Hz), 55.4,
1
114.5, 116.7, 121.1, 124.4, 126.7 (q, JC,F = 290 Hz), 143.5,
153.2 ppm. 19F NMR: δ = –70.8 (d, JH,F = 8.5 Hz, CF3) ppm.
C13H14F3NO (257.29): calcd. C 60.70, H 5.49, N 5.44; found C
60.59, H 5.51, N 5.45.
1-(4-Methoxyphenyl)-5-methyl-2-trifluoromethyl-1,2,3,6-tetrahydro-
pyridine (23): Starting from 14 (136 mg, 0.45 mmol) and the
Grubbs catalyst (21 mg, 7 mol-%), compound 23 was obtained as
H) ppm. 13C NMR: δ = 24.2 (q, JC,F = 2.0 Hz), 44.1, 56.1 (q,
3
2JC,F = 26 Hz), 59.1, 121.5, 125.1, 125.3 (q, 1JC,F = 293 Hz), 127.1,
128.3, 128.4, 138.7 ppm. 19F NMR: δ = –68.6 (d, JH,F = 9.0 Hz,
CF3) ppm. C13H14F3N (241.26): calcd. C 64.72, H 5.85, N 5.81;
found C 64.99, H, 5.78, N 5.88.
1
a brown liquid (47 mg, 41%). H NMR: δ = 1.8 (s, 3 H), 2.4 (d, J
= 17.9 Hz, 1 H), 2.7 (d, J = 17.9 Hz, 1 H), 3.5 (d, J = 16.9 Hz, 1
H), 3.7 (d, J = 16.9 Hz, 1 H), 3.8 (s, 3 H), 4.4 (q, J = 8.3 Hz, 1 H),
5.5 (m, 1 H), 6.8–6.9 (m, 4 H) ppm. 13C NMR: δ = 20.6, 24.1 (q,
1-Benzyl-3,3-dimethyl-2-trifluoromethyl-1,2,3,6-tetrahydropyridine
(18): Starting from 8 (134 mg, 0.45 mmol) and the Grubbs catalyst
(18 mg, 5 mol-%), compound 18 was obtained as a clear, brown
2
3JC,F = 1.6 Hz), 48.3, 54.1 (q, JC,F = 27.0 Hz), 55.5, 114.6, 115.7,
1
116.9, 126.9 (q, JC,F = 292 Hz), 131.4, 143.4, 153.3 ppm. 19F
1
liquid (116 mg, 96%). H NMR: δ = 1.1–1.3 (m, 6 H), 3.0 (q, J =
NMR: δ = –70.8 (d, J = 8.3 Hz, CF3) ppm. C14H16F3NO (271.28):
calcd. C 61.98, H 5.94, N, 5.16; found C 61.82, H 6.06, N 5.04.
9.0 Hz, 1 H), 3.2 (m, 2 H), 4.0 (m, 2 H), 5.4 (m, 1 H), 5.6 (td, J =
3.1, 10 Hz, 1 H), 7.3–7.4 (m, 5 H) ppm. 13C NMR: δ = 24.8, 31.4,
(–)-1-(2-Methoxy-1-phenylethyl)-2-trifluoromethyl-1,2,3,6-tetrahy-
dropyridine (24): Starting from 16 (258 mg, 0.82 mmol) and the
Grubbs catalyst (56 mg, 7 mol-%), compound 24 was obtained as
a brown liquid (214 mg, 98%). [α]2D5–26.4 (c = 0.265 in MeOH). 1H
NMR: δ = 2.1 (d, J = 18.0 Hz, 1 H), 2.5 (d, J = 18.0 Hz, 1 H), 3.0
(d, J = 17.6 Hz, 1 H), 3.1 (d, J = 17.6 Hz, 1 H), 3.2 (s, 3 H), 3.62
(d, J = 5.7 Hz, 1 H), 3.63 (d, J = 4.4 Hz, 1 H), 3.7 (m, 1 H), 4.0
(t, J = 5.2 Hz, 1 H), 5.5–5.7 (m, 2 H), 7.2–7.4 (m, 5 H) ppm. 13C
2
1
46.3, 60.4, 66.7 (q, JC,F = 23 Hz), 122.3, 127.1, 128.0 (q, JC,F
=
297 Hz), 128.2, 128.5, 133.1, 139.0 ppm. 19F NMR: δ = –62.2 (d,
JH,F = 9.0 Hz, CF3) ppm. C15H18F3N (269.31): calcd. C 66.90, H
6.74, N 5.20; found C 66.58, H, 6.69, N 5.31.
1-Benzyl-4-methyl-2-trifluoromethyl-1,2,3,6-tetrahydropyridine (19):
Starting from diene 9 (127 mg, 0.45 mmol) and the Grubbs catalyst
(18 mg, 5 mol-%), compound 19 was obtained as a clear, brown
1
2
liquid (107 mg, 93%). H NMR: δ = 1.4 (s, 3 H), 2.0 (m, 1 H), 2.4
NMR: δ = 24.1, 44.8, 53.8 (q, JC,F = 27.0 Hz), 58.8, 66.0, 75.0,
1
(m, 1 H), 3.1 (m, 2 H), 3.5 (m, 1 H), 3.9 (qd, J = 14.0, 1.6 Hz, 1
H), 4.0 (d, J = 14.0 Hz, 1 H), 5.4 (m, 1 H), 7.2–7.4 (m, 5 H) ppm.
121.7, 125.5, 127.4, 127.9 (q, JC,F = 292 Hz), 127.9, 128.3, 141.0
ppm. 19F NMR: δ = –69.6 (d, J = 9.0 Hz, CF3) ppm. C15H18F3NO
(285.30): calcd. C 63.15, H 6.36, N 4.91; found C 63.26, H 6.52, N
4.98.
13C NMR: δ = 22.7, 28.6 (q, JC,F = 2.0 Hz), 47.3, 56.7 (q, JC,F
=
3
2
26.0 Hz), 58.7, 119.9, 127.1, 127.7 (q, 1JC,F = 292 Hz), 128.3, 128.4,
128.9, 138.7 ppm. 19F NMR (CDCl3): δ = –68.8 (d, JH,F = 9.0 Hz,
CF3) ppm. C14H16F3N (255.29): calcd. C 65.87, H 6.32, N 5.49;
found C 65.06, H 6.25, N 5.58.
Synthesis of 2-Benzyl-3-trifluoromethyl-1,2,3,6,7,7a-hexahydro-
[2]pyrindin-6-one (25): Co2(CO)8 (261 mg, 0.76 mmol) was added to
a solution of 10 (170 mg, 0.64 mmol) in CH2Cl2 (4 mL) under an
1-Benzyl-5-methyl-2-trifluoromethyl-1,2,3,6-tetrahydropyridine (20): argon atmosphere. After disappearance of the starting material
Starting from 13 (160 mg, 0.6 mmol) and the Grubbs catalyst
(44 mg, 20 mol-%), compound 20 was obtained as a clear, brown
liquid (128 mg, 89 %). 1H NMR: δ = 1.5 (s, 3 H), 2.1 (d, J =
(0.5 h; monitored by TLC), the reaction mixture was cooled to
0 °C, and N-methylmorpholine N-oxide monohydrate (774 mg,
5.7 mmol) was added in several portions over 15 min. The reaction
Eur. J. Org. Chem. 2005, 1258–1265
© 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1263